Novus Biologicals Announces Second Distribution Partner in China

Littleton, Colo. “March 3, 2014“ Novus Biologicals, a leading developer and marketer of life sciences research products, is pleased to announce a second distribution partner in China, MultiSciences (LIANKE) Biotech Co., Ltd.

R&D expenditures in China increased from $2 billion in 2007 to $8.4 billion in 2012, a compound annual growth rate of 32.8%.1As the most rapidly growing nation in the Asia Pacific, we realize the importance of focusing on China and increasing the availability and support of our products via additional distribution channels. We are thrilled to be partnering with MultiSciences, stated Dave Eansor, Novus Biologicals™ Senior Vice President of Corporate Development.

This new distribution channel broadens Novus Biologicals™ already strong presence in China to better serve the rapidly growing research market in China and the greater Asia Pacific. MultiSciences is now one of Novus Biologicals™ 30 international distribution partners. The partnership between Novus Biologicals and MultiSciences enables life science researchers in China to obtain antibodies and other research reagents quickly, efficiently, and with robust customer and technical support in their local language. Novus Biologicals continues to serve markets in China and Hong Kong through their long-standing relationship with Genetimes Technology, Inc.

About Novus Biologicals, LLC

Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing life science research products. Novus Biologicals provides antibodies and reagents for life science research of neurosciences, immunology, cellular response to stress, and cancer research. Novus Biologicals acquired Imgenex Corporation in October 2013. For more information, visit

About MultiSciences (LIANKE) Biotech Co., Ltd.

MultiSciences is a leading distributor of life science reagents headquartered in Hangzhou, Zhejiang province, China. MultiSciences was established in 2001. In addition to the headquarter office in Hangzhou, branch offices are also located in Beijing, Guangzhou, Shanghai, Tianjing, Suzhou, and Nanjing. MultiSciences specializes in providing research reagents for the study of cell biology and immunology. For more information, visit


Amy Chamberlain-Torres
Director of Commercial Operations APAC Novus Biologicals, LLC


1 Chakma, J., Sun, G.H., Steinberg, J.D., Sammut, S.M., Jagsi, R. (2014). Asia’s Ascent Global Trends in Biomedical R&D Expenditures. The New England Journal of Medicine, 370; 3-6.

Release Date: 
Monday, March 3, 2014 - 07:00